Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043261 · ClinicalTrials.gov registry record · NA
Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation
A NA study of Congestive Heart Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03043261: Completed NA study of Congestive Heart Failure, sponsored by Duke University.
NCT03043261 is a NA study of Congestive Heart Failure that has completed, run by Duke University. The registered enrollment target is 3 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043261, a NA study of Congestive Heart Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalization due to heart failure exacerbation.
Primary Outcome
Percentage of subjects who complete the intervention
Conditions Studied
Interventions
- BEHAVIORAL Williams LifeSkills
Study Locations (1)
North Carolina
- Pamela Bonner - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2018-04-07 |
| Phase | NA |
What the finished NCT03043261 record still lists
NCT03043261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Williams LifeSkills is the first listed.
NCT03043261 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03043261 about?
NCT03043261 is a clinical study titled "Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation". EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalizati...
What is the current status of trial NCT03043261?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2018-01-29. Estimated completion is 2018-04-07.
What conditions does trial NCT03043261 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT03043261?
The interventions under investigation include: Williams LifeSkills (BEHAVIORAL).
Who is sponsoring clinical trial NCT03043261?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03043261 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03043261's enrollment target sits among peer trials
3 52nd of 51 the lowest of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI